Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-4-26
pubmed:abstractText
We investigated the outcomes of paclitaxel and cisplatin chemotherapy as an optional regimen for patients with metastatic urothelial carcinoma after failure of two consecutive platinum-based regimens.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1442-2042
pubmed:author
pubmed:copyrightInfo
© 2011 The Japanese Urological Association.
pubmed:issnType
Electronic
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
350-7
pubmed:meshHeading
pubmed-meshheading:21355894-Adult, pubmed-meshheading:21355894-Aged, pubmed-meshheading:21355894-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:21355894-Carcinoma, pubmed-meshheading:21355894-Cisplatin, pubmed-meshheading:21355894-Disease-Free Survival, pubmed-meshheading:21355894-Doxorubicin, pubmed-meshheading:21355894-Female, pubmed-meshheading:21355894-Gentamicins, pubmed-meshheading:21355894-Humans, pubmed-meshheading:21355894-Kaplan-Meier Estimate, pubmed-meshheading:21355894-Kidney Neoplasms, pubmed-meshheading:21355894-Lung Neoplasms, pubmed-meshheading:21355894-Male, pubmed-meshheading:21355894-Methotrexate, pubmed-meshheading:21355894-Middle Aged, pubmed-meshheading:21355894-Paclitaxel, pubmed-meshheading:21355894-Retrospective Studies, pubmed-meshheading:21355894-Treatment Failure, pubmed-meshheading:21355894-Ureteral Neoplasms, pubmed-meshheading:21355894-Urinary Bladder Neoplasms, pubmed-meshheading:21355894-Urothelium, pubmed-meshheading:21355894-Vinblastine
pubmed:year
2011
pubmed:articleTitle
Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens.
pubmed:affiliation
Center for Prostate Cancer, National Cancer Center, Goyang, Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't